A peer-reviewed article by researchers at the University of Shanghai for Science and Technology (USST), published in an international biomedical engineering journal, reports that the Hextra Tech™ ...
As the first and only state contracting for its own affordable insulin, Governor Gavin Newsom announced Oct. 16 that CalRx® ...
EL SEGUNDO, Calif. — Gov. Gavin Newsom announced Thursday that CalRx biosimilar insulin glargine pens will be available to consumers in California beginning Jan. 1, 2026. The launch comes amid the ...
(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...
TipRanks on MSN
Insulet’s New Study on Simplified Onboarding for Type 2 Diabetes Management: A Potential Game Changer
Insulet (($PODD)) announced an update on their ongoing clinical study. Insulet Corporation is currently conducting a study titled ‘Feasibility of ...
For many elderly diabetics, daily insulin injections become harder to manage with age-related cognitive decline. Missed doses ...
7d
Democratic Gov. Gavin Newsom of California says he'll consider presidential run after 2026 midterms
California Gov. Gavin Newsom, a leading Democratic critic of President Donald Trump, says he'll consider running for the ...
California will begin selling long-acting, low-cost insulin in January, becoming the first state to bypass major pharmaceutical companies, Gov. Gavin Newsom (D-CA) announced Thursday. The move marks a ...
Gov. Gavin Newsom announces a partnership with Civica Rx to provide insulin to Californians for $30 for 10 milliliters, which he said was as little as one-tenth of the current cost. Photo by Ringo ...
LEHI, Utah, Oct. 16, 2025 /PRNewswire/ -- Non-profit pharmaceutical company Civica will launch an affordable long-acting insulin – insulin glargine-yfgn in pre-filled pens – at the lowest list price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback